{"id":"https://openalex.org/W2994066142","doi":null,"title":"[The efficacy and safety of a therapy regimen including raltegravir and a fixed dose combination of lamivudine and abacavir in previously rifabutin-treated patients with tuberculosis and HIV infection].","display_name":"[The efficacy and safety of a therapy regimen including raltegravir and a fixed dose combination of lamivudine and abacavir in previously rifabutin-treated patients with tuberculosis and HIV infection].","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2994066142","mag":"2994066142","pmid":"https://pubmed.ncbi.nlm.nih.gov/25715485"},"language":"ru","primary_location":{"id":"pmid:25715485","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25715485","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Terapevticheskii arkhiv","raw_type":"English Abstract"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doaj.org/article/323218680c27494fb049e6d94a4e5c7a","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055386699","display_name":"Aleksei V. Kravchenko","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A V Kravchenko","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030675786","display_name":"\u0412. \u041d. \u0417\u0438\u043c\u0438\u043d\u0430","orcid":"https://orcid.org/0000-0003-3726-9022","observed_orcids":["https://orcid.org/0000-0003-3726-9022"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V N Zimina","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025337904","display_name":"\u0410. \u0410. \u041f\u043e\u043f\u043e\u0432\u0430","orcid":"https://orcid.org/0000-0001-9484-5917","observed_orcids":["https://orcid.org/0000-0001-9484-5917"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A A Popova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046786675","display_name":"M O Deulina","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M O Deulina","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031854153","display_name":"V G Kanestri","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V G Kanestri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056753054","display_name":"Elvira S. Ivanova","orcid":"https://orcid.org/0000-0001-8756-9854","observed_orcids":["https://orcid.org/0000-0001-8756-9854"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E S Ivanova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112708615","display_name":"Alexey A. Yakovlev","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A A Yakovlev","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5066222630","display_name":"Vadim Valentinovich Pokrovsky","orcid":"https://orcid.org/0000-0002-9514-7288","observed_orcids":["https://orcid.org/0000-0002-9514-7288"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V V Pokrovsky","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2213,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.5385052,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"86","issue":"11","first_page":"34","last_page":"41"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11381","display_name":"Infectious Diseases and Tuberculosis","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/raltegravir","display_name":"raltegravir","score":0.9769999980926514},{"id":"https://openalex.org/keywords/lamivudine","display_name":"lamivudine","score":0.8679999709129333},{"id":"https://openalex.org/keywords/abacavir","display_name":"abacavir","score":0.9950000047683716},{"id":"https://openalex.org/keywords/fixed-dose-combination-antiretroviral-therapy","display_name":"fixed-dose combination antiretroviral therapy","score":0.8560000061988831},{"id":"https://openalex.org/keywords/hiv-tb-co-infection","display_name":"HIV/TB coinfection","score":0.7649999856948853},{"id":"https://openalex.org/keywords/rifabutin","display_name":"rifabutin","score":0.9490000009536743},{"id":"https://openalex.org/keywords/tuberculosis-treatment","display_name":"tuberculosis treatment","score":0.8939999938011169},{"id":"https://openalex.org/keywords/antiretroviral-therapy-efficacy","display_name":"antiretroviral therapy efficacy","score":0.7049999833106995},{"id":"https://openalex.org/keywords/cd4-count","display_name":"CD4 count","score":0.8149999976158142},{"id":"https://openalex.org/keywords/hiv-rna-suppression","display_name":"HIV RNA suppression","score":0.746999979019165},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7450000047683716},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6019999980926514},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.5630000233650208}],"concepts":[{"id":"https://openalex.org/C2780404665","wikidata":"https://www.wikidata.org/wiki/Q421552","display_name":"Raltegravir","level":5,"score":0.884363055229187},{"id":"https://openalex.org/C2779465607","wikidata":"https://www.wikidata.org/wiki/Q304330","display_name":"Abacavir","level":5,"score":0.8471659421920776},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7805880308151245},{"id":"https://openalex.org/C2777869810","wikidata":"https://www.wikidata.org/wiki/Q422631","display_name":"Lamivudine","level":4,"score":0.7367100119590759},{"id":"https://openalex.org/C2780867798","wikidata":"https://www.wikidata.org/wiki/Q1135705","display_name":"Rifabutin","level":4,"score":0.7267845869064331},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6208295226097107},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5862739682197571},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5400998592376709},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.49430418014526367},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.4882185757160187},{"id":"https://openalex.org/C2776623344","wikidata":"https://www.wikidata.org/wiki/Q5456317","display_name":"Fixed-dose combination","level":2,"score":0.48494818806648254},{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.46596506237983704},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.4168045222759247},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.40595072507858276},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.2985331118106842},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.28571242094039917},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.27747607231140137},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09381315112113953},{"id":"https://openalex.org/C2776962512","wikidata":"https://www.wikidata.org/wiki/Q118551","display_name":"Clarithromycin","level":3,"score":0.07959109544754028},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.07956337928771973},{"id":"https://openalex.org/C2776409635","wikidata":"https://www.wikidata.org/wiki/Q180556","display_name":"Helicobacter pylori","level":2,"score":0.0},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000068898","descriptor_name":"Raltegravir Potassium","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000099227","descriptor_name":"Abacavir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000904","descriptor_name":"Antibiotics, Antitubercular","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000904","descriptor_name":"Antibiotics, Antitubercular","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011760","descriptor_name":"Pyrrolidinones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011760","descriptor_name":"Pyrrolidinones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011760","descriptor_name":"Pyrrolidinones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012367","descriptor_name":"RNA, Viral","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014376","descriptor_name":"Tuberculosis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D014376","descriptor_name":"Tuberculosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015224","descriptor_name":"Dideoxynucleosides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015224","descriptor_name":"Dideoxynucleosides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015224","descriptor_name":"Dideoxynucleosides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017828","descriptor_name":"Rifabutin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017828","descriptor_name":"Rifabutin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018791","descriptor_name":"CD4 Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019259","descriptor_name":"Lamivudine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019259","descriptor_name":"Lamivudine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019259","descriptor_name":"Lamivudine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:25715485","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25715485","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Terapevticheskii arkhiv","raw_type":"English Abstract"},{"id":"pmh:oai:doaj.org/article:323218680c27494fb049e6d94a4e5c7a","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/323218680c27494fb049e6d94a4e5c7a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"\u0422\u0435\u0440\u0430\u043f\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0430\u0440\u0445\u0438\u0432, Vol 86, Iss 11, Pp 34-41 (2014)","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:doaj.org/article:323218680c27494fb049e6d94a4e5c7a","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/323218680c27494fb049e6d94a4e5c7a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"\u0422\u0435\u0440\u0430\u043f\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0430\u0440\u0445\u0438\u0432, Vol 86, Iss 11, Pp 34-41 (2014)","raw_type":"article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2160104000","https://openalex.org/W3133643949","https://openalex.org/W1965406487","https://openalex.org/W2064500065","https://openalex.org/W2801057928","https://openalex.org/W2092988016","https://openalex.org/W4394301975","https://openalex.org/W7097281041","https://openalex.org/W7018843664","https://openalex.org/W4392464809"],"abstract_inverted_index":{"AIM:":[0],"To":[1],"evaluate":[2],"the":[3,95,99,111,117,129,137,142,147,150,156,179,204,211,244,283,333],"efficiency":[4,53],"and":[5,30,41,68,106,126,176,188,198,213,257,281,304],"safety":[6],"of":[7,21,54,109,113,128,149,196,210,216,241,248,253,293,309,335,338],"using":[8,325],"raltegravir":[9],"(RAL)":[10],"twice":[11],"daily":[12],"in":[13,25,58,64,72,124,144,181,203,208,220,225,235,239,295],"conjunction":[14],"with":[15,27,146,169,171,314,317],"a":[16,62,226,231,273,305],"once-daily":[17],"fixed":[18,306],"dose":[19,307],"combination":[20,308],"abacavir":[22],"(ABC)/lamivudine":[23],"(3TC)":[24],"patients":[26,60,96,138,212,313],"HIV":[28,65,114,318],"infection":[29,223,319],"active":[31],"tuberculosis":[32,315,328],"who":[33,139,320],"have":[34,42,272],"not":[35,290],"previously":[36],"received":[37],"antiretroviral":[38],"therapy":[39,47,91,158,324],"(ART)":[40],"taken":[43],"rifabutin":[44,256,326],"as":[45],"antituberculosis":[46],"(ATT).":[48],"SUBJECTS":[49],"AND":[50],"METHODS:":[51],"The":[52,87,193,250,299],"ART":[55,197,259,300],"was":[56,93,164,186,264,269,289],"evaluated":[57],"28":[59],"from":[61,69],"change":[63],"RNA":[66,115],"levels":[67],"an":[70,134,258],"increase":[71,180],"CD4+":[73,183],"lymphocyte":[74,184],"counts":[75,185],"during":[76],"48-week":[77,177],"treatment":[78,334],"that":[79,94],"had":[80,140],"been":[81],"completed":[82,141],"by":[83,230],"15":[84],"(53.6%)":[85],"patients.":[86,339],"main":[88],"reason":[89],"for":[90,311,327,332],"discontinuation":[92],"returned":[97],"to":[98,133,160,166,271,285],"use":[100,195,252],"psychoactive":[101],"agents.":[102],"RESULTS:":[103],"After":[104],"24":[105],"48":[107],"weeks":[108,247],"ART,":[110],"level":[112],"reached":[116],"undetectable":[118],"values":[119],"(less":[120],"than":[121],"50":[122],"copies/ml)":[123],"81.25":[125],"75%":[127],"patients,":[130,155,238],"respectively":[131],"(according":[132],"analysis":[135],"including":[136,255],"study":[143],"conformity":[145],"requirements":[148],"protocol).":[151],"In":[152],"only":[153],"2":[154,240],"virological":[157],"proved":[159],"be":[161,167,330],"ineffective,":[162],"which":[163],"likely":[165],"associated":[168],"noncompliance":[170],"drug":[172],"therapy.":[173,287],"Following":[174],"24-":[175],"therapy,":[178],"median":[182],"70":[187],"208.5":[189],"per":[190],"\u03bcl,":[191],"respectively.":[192],"concurrent":[194,316],"ATT":[199,254,288],"caused":[200,229,282],"positive":[201],"changes":[202],"lung":[205,217],"skiagraphic":[206],"pattern":[207],"92.9%":[209],"complete":[214],"resolution":[215],"tissue":[218],"infiltration":[219],"71.4%.":[221],"Mixed":[222],"ended":[224],"fatal":[227],"outcome":[228],"progressive":[232],"tuberculous":[233],"process":[234],"3":[236],"(10.7%)":[237],"them":[242],"within":[243],"first":[245],"8":[246],"treatment.":[249],"concomitant":[251],"(RAL":[260],"+":[261],"ABC/3TC)":[262],"regimen":[263,301],"safe":[265],"since":[266],"one":[267],"patient":[268,284],"noted":[270],"RAL-related":[274],"adverse":[275],"event":[276],"(AE)":[277],"(an":[278],"allergic":[279],"reaction)":[280],"discontinue":[286],"discontinued":[291],"because":[292],"AE":[294],"any":[296],"case.":[297],"CONCLUSION:":[298],"containing":[302],"RAL":[303],"ABC/3TC":[310],"adult":[312],"are":[321],"on":[322],"combined":[323],"may":[329],"recommended":[331],"this":[336],"category":[337]},"counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2019-12-13T00:00:00"}